290,000 doses of Pentavalent vaccine arrive in Iran to support routine immunization
- فارسي، فارسي
- English
UNICEF has supported the delivery of 290,000 doses of Pentavalent vaccine to Iran, helping ensure the continuity of routine immunization services for children across the country.
The vaccines arrived in May 2026 through close collaboration between UNICEF, the Ministry of Health and Medical Education (MoHME), and the MoHME designated private-sector partner. The shipment is part of ongoing efforts to maintain a reliable supply of essential vaccines despite challenges like sanctions which affecting global procurement and supply chains.
Protecting children from vaccine-preventable diseases
The Pentavalent vaccine protects children against five serious diseases: diphtheria, tetanus, pertussis (whooping cough), hepatitis B, and Haemophilus influenzae type b (Hib). As a cornerstone of Iran’s routine immunization programme, the vaccine plays a vital role in protecting children’s health and reducing preventable illness and death.
Building on this achievement, UNICEF will continue supporting the procurement and importation process, with an additional 2.3 million doses of Pentavalent vaccine expected to arrive in the coming months.
UNICEF has long partnered with national authorities to support vaccine supply and strengthen immunization services in Iran, helping ensure that every child has access to life-saving protection.
Media contacts
About UNICEF
UNICEF promotes the rights and wellbeing of every child, in everything we do. Together with our partners, we work in 190 countries and territories to translate that commitment into practical action, focusing special effort on reaching the most vulnerable and excluded children, to the benefit of all children, everywhere.
For more information about UNICEF and its work for children, visit www.unicef.org.
